Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Seagen Inc.
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
Merck Sharp & Dohme LLC
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Royal Marsden NHS Foundation Trust
Merck Sharp & Dohme LLC
University of California, Irvine
Tongji Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Erasmus Medical Center
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
OncXerna Theraputics, Inc.
ExcellaBio LLC
Hoffmann-La Roche
MultiVir, Inc.
Cornerstone Pharmaceuticals
National University Hospital, Singapore
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center
Georgetown University
National Cancer Center, Korea
National Institutes of Health Clinical Center (CC)